News

Published on 17 Oct 2022 on Simply Wall St. via Yahoo Finance

The past five years for Enzo Biochem (NYSE:ENZ) investors has not been profitable


Article preview image

Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic capital loss on anyone. For example, we sympathize with anyone who was caught holding Enzo Biochem, Inc. (NYSE:ENZ) during the five years that saw its share price drop a whopping 79%. We also note that the stock has performed poorly over the last year, with the share price down 44%. More recently, the share price has dropped a further 21% in a month. But this could be related to poor market conditions -- stocks are down 9.2% in the same time.

Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.

Check out our latest analysis for Enzo Biochem

NYSE.ENZ price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges

Shares of Enzo Biochem, Inc. ENZ have tumbled 30.9% since the release of its earnings report for ...

Zacks · via Yahoo Finance 19 Dec 2024

Top Stock Reports for Amgen, Eaton & Enzo Biochem

Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AM...

Zacks · via Yahoo Finance 4 Dec 2024

Zacks Initiates Coverage of Enzo Biochem With Neutral Recommendation

Zacks Investment Research has recently initiated coverage of Enzo Biochem, Inc. ENZ, assigning a ...

Zacks · via Yahoo Finance 19 Jun 2024

Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up

Enzo Biochem, Inc. ENZ delivered a loss per share of 4 cents from continuing operations in the th...

Zacks · via Yahoo Finance 19 Jun 2024

Enzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years...

Investing in stocks inevitably means buying into some companies that perform poorly. But the long...

Simply Wall St. via Yahoo Finance 14 Mar 2024

Jim Simons Trims Stake in Enzo Biochem Inc

Recent Stock Transaction Overview On December 29, 2023, Renaissance Technologies, led by Jim Simo...

GuruFocus.com via Yahoo Finance 14 Feb 2024

Here’s Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)

Laughing Water Capital, an investment management company, released its fourth-quarter 2023 invest...

Insider Monkey via Yahoo Finance 28 Jan 2024

Enzo Biochem (NYSE:ENZ) shareholders have endured a 63% loss from investing in the stock five years...

Generally speaking long term investing is the way to go. But unfortunately, some companies simply...

Simply Wall St. via Yahoo Finance 6 Oct 2023

Here’s Why Laughing Water Capital Made a Position in Enzo Biochem (ENZ)

Laughing Water Capital, an investment management company, released its second-quarter 2023 invest...

Insider Monkey via Yahoo Finance 19 Jul 2023

Enzo Biochem, Inc.'s (NYSE:ENZ) Popularity With Investors Is Under Threat From Overpricing

There wouldn't be many who think Enzo Biochem, Inc.'s (NYSE:ENZ) price-to-sales (or "P/S") ratio ...

Simply Wall St. via Yahoo Finance 8 Jun 2023